Search
-
News
A new study suggests a way to target cancer by interfering with its system of waste removal.
… Wednesday, March 20, 2019 Summary Scientists at the Sloan Kettering Institute have linked a type of protein damage called glycation to cancer and other diseases. Glycation is caused by the buildup of cellular waste products. New Yorkers are familiar with the sight (and smell) of uncollected garbage piled
-
News
Learn how disrupting a gene called SUV39H1 could make CAR T cells more powerful.
… Friday, November 10, 2023 CAR T cell therapy , a powerful type of immunotherapy , has begun to revolutionize cancer treatment . Pioneered at Memorial Sloan Kettering Cancer Center (MSK), the therapy involves engineering a patient’s T cells so they recognize and attack cancer cells. These CAR (chimeric
-
News
MSK announces the establishment of the Marie-Josée Kravis Women in Science Endeavor (WiSE) to provide financial and professional support to women scientists pursuing biomedical research at MSK, pledging its commitment to gender equity in science and paving the way for more women to become leaders in their field.
… Tuesday, July 7, 2020 Memorial Sloan Kettering Cancer Center (MSK) announces the establishment of the Marie-Josée Kravis Women in Science Endeavor ( WiSE ) to provide financial and professional support to women scientists pursuing biomedical research at MSK, pledging its commitment to gender equity
-
News
Hear from a medical student that participated in the Summer Pipeline Program.
… Monday, December 5, 2022 Ray Hunter’s grandfather used to tell him, “You can’t go to the doctor, you can’t trust them. They don’t treat those who look like us well.” As a Black man, Ray knows his grandfather’s fear was real. It’s one of the primary reasons he decided to pursue a career in medicine. “
-
News
Three Memorial Sloan Kettering Cancer Center investigators -- including the Center's new President, Craig B. Thompson -- have been featured with singer-songwriter Debbie Harry to lead the Geoffrey Beene Gives Back® 2010 Rock Stars of Science™ campaign in GQ magazine's December "Men of the Year" issue.
… Saturday, January 1, 2011 Summary Three Memorial Sloan Kettering Cancer Center investigators — including the Center’s new President, Craig B. Thompson — have been featured with singer-songwriter Debbie Harry to lead the Geoffrey Beene Gives Back® 2010 Rock Stars of Science™ campaign in GQ magazine’s
-
News
The findings will change how women with intermediate-risk breast cancer are treated.
… Sunday, June 3, 2018 Summary New clinical trial results show that women with intermediate-risk breast cancer treated with endocrine therapy alone fared just as well as those treated with chemotherapy plus endocrine therapy. In light of the findings, medical oncologist Larry Norton says that standard
-
News
Find out what’s contributing to a marked increase in the death rate for liver cancer.
… Monday, October 15, 2018 Summary Liver cancer death rates have risen sharply in recent years, in part due to an increase in chronic conditions that cause damage to the liver. Meanwhile, recent advances in liver cancer treatment have improved the outlook for people with the disease. Liver cancer death
-
News
During the early days of the COVID-19 outbreak, a team of radiation oncologists specializing in breast cancer management at Memorial Sloan Kettering Cancer Center reviewed the literature and established recommendations for the safe use of hypofractionated and abbreviated radiation regimens for our patients with breast cancer.
… Monday, May 11, 2020 As governments and health authorities restrict in-person interactions to contain the spread of COVID-19, radiation oncologists must make unprecedented decisions on behalf of patients needing radiotherapy. We must balance the risk of presenting for treatment with being exposed to
-
MSK News
Learn about immunotherapy advances for cancer treatment from Dr. Selwyn Vickers, President and CEO of Memorial Sloan Kettering.
… Tuesday, November 7, 2023 Dear MSK Community, Every day we are inspired when our patients are given new hope, thanks to a lifesaving approach to cancer treatment that was pioneered at MSK — immunotherapy . The premise is straightforward: Encourage a person’s own immune system to overpower cancer cells
-
News
MSK physicians and scientists are involved in notable research to be presented during the virtual meeting.
… Friday, September 18, 2020 Thousands of oncology experts from around the world will tune in September 19 to 21 for the European Society for Medical Oncology’s (ESMO) Virtual Congress. During the virtual meeting, experts will present promising new developments aimed at improving cancer patient care. This